Literature DB >> 17651930

Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.

Youssef Jallouli1, Archibald Paillard, Jiang Chang, Emmanuel Sevin, Didier Betbeder.   

Abstract

The aim of these studies was to evaluate the binding, uptake and transcytosis of 60 nm porous nanoparticles (NPs) that differed in their surface charge and inner composition on the blood-brain barrier (BBB). They were prepared from maltodextrins derived with or without a cationic ligand. In the cationic NPs an anionic lipid was inserted in their core to give DPPG-NPs. The data showed that at 4 degrees C the three NPs bind in different areas on endothelial cells: cationic NPs were found mainly around the paracellular area, while neutral NPs were mainly on the cell surface and DPPG-NPs binding was found at both paracellular areas and on the surface of the cells. At 37 degrees C neutral and cationic NPs had similar degrees of binding and uptake and were transcytosed. Filipin treatment increased their binding and uptake suggesting that sterols are implied in their efflux. Neutral NPs transcytosis was also inhibited by filipin. This inhibition shows that neutral NPs, like LDL in this model, use the caveolae pathway. Neutral and cationic 60 nm porous NPs are potential candidates for drug delivery to the brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651930     DOI: 10.1016/j.ijpharm.2007.06.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  25 in total

Review 1.  In vivo methods to study uptake of nanoparticles into the brain.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Wim E Hennink; Gert Storm; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

2.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

3.  Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells.

Authors:  M Malatesta; V Galimberti; B Cisterna; M Costanzo; M Biggiogera; C Zancanaro
Journal:  Histochem Cell Biol       Date:  2013-12-20       Impact factor: 4.304

4.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

Review 5.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

Review 6.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

7.  Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers.

Authors:  Archibald Paillard; Catherine Passirani; Patrick Saulnier; Maya Kroubi; Emmanuel Garcion; Jean-Pierre Benoît; Didier Betbeder
Journal:  Pharm Res       Date:  2009-10-23       Impact factor: 4.200

8.  Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

Authors:  Elizabeth Nance; Fan Zhang; Manoj K Mishra; Zhi Zhang; Siva P Kambhampati; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Biomaterials       Date:  2016-05-26       Impact factor: 12.479

Review 9.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

10.  Maltodextrin modified liposomes for drug delivery through the blood-brain barrier.

Authors:  Zeynep Gurturk; Aysen Tezcaner; Ali Deniz Dalgic; Seval Korkmaz; Dilek Keskin
Journal:  Medchemcomm       Date:  2017-05-05       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.